IRIS
SINAGRA, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.611
AS - Asia 3.348
EU - Europa 2.762
SA - Sud America 676
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 98
OC - Oceania 8
Totale 12.609
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.339
SG - Singapore 1.178
IT - Italia 1.117
CN - Cina 842
RU - Federazione Russa 645
BR - Brasile 503
VN - Vietnam 466
BD - Bangladesh 266
HK - Hong Kong 208
DE - Germania 207
CA - Canada 156
GB - Regno Unito 154
FR - Francia 110
SE - Svezia 99
IN - India 84
IE - Irlanda 76
AR - Argentina 70
FI - Finlandia 69
NL - Olanda 64
MX - Messico 56
PL - Polonia 55
TR - Turchia 47
ZA - Sudafrica 46
PK - Pakistan 41
ID - Indonesia 38
ES - Italia 36
UA - Ucraina 35
EC - Ecuador 31
JP - Giappone 31
IQ - Iraq 30
CO - Colombia 28
AT - Austria 23
LT - Lituania 20
IL - Israele 18
VE - Venezuela 18
SA - Arabia Saudita 17
JM - Giamaica 15
UZ - Uzbekistan 15
AE - Emirati Arabi Uniti 12
BE - Belgio 12
MA - Marocco 10
CL - Cile 9
EG - Egitto 9
KE - Kenya 9
CH - Svizzera 8
MY - Malesia 8
TN - Tunisia 8
CR - Costa Rica 7
JO - Giordania 7
OM - Oman 7
HN - Honduras 6
SI - Slovenia 6
KZ - Kazakistan 5
PE - Perù 5
PR - Porto Rico 5
PY - Paraguay 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
ET - Etiopia 4
HR - Croazia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
PH - Filippine 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
KR - Corea 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BS - Bahamas 2
BZ - Belize 2
CY - Cipro 2
EE - Estonia 2
GP - Guadalupe 2
GR - Grecia 2
GT - Guatemala 2
MD - Moldavia 2
NO - Norvegia 2
RO - Romania 2
SV - El Salvador 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
Totale 12.493
Salva come PNG Salva come JPEG
Città #
Dallas 1.832
Singapore 665
San Jose 558
Ashburn 444
Council Bluffs 290
Beijing 277
Milan 192
Hong Kong 189
Ho Chi Minh City 169
Los Angeles 152
New York 130
Rome 114
Moscow 104
Santa Clara 99
Phoenix 98
Hanoi 87
Dublin 76
Chandler 61
Munich 58
São Paulo 57
Orem 53
Buffalo 51
Lauterbourg 49
The Dalles 47
Warsaw 45
Hefei 44
Montreal 43
Frankfurt am Main 36
Helsinki 36
Brooklyn 34
Johannesburg 34
Naples 34
Boardman 31
Chennai 31
San Mateo 30
Bologna 29
Columbus 29
Tokyo 29
Denver 28
Pisa 28
London 27
Mexico City 27
Seattle 26
Atlanta 25
Houston 25
Ottawa 25
Chicago 24
Turin 24
Amsterdam 23
Beauharnois 22
Fairfield 22
Lappeenranta 22
Nuremberg 22
Poplar 22
Haiphong 21
Cambridge 20
Boston 19
Genoa 19
Istanbul 19
Florence 18
Da Nang 17
Portsmouth 17
Toronto 17
Washington 17
Stockholm 16
West Jordan 16
Brasília 15
Rio de Janeiro 15
San Francisco 15
Wilmington 15
Ankara 14
Padua 14
Stevenage 14
Tashkent 14
Tel Aviv 14
Kochi 13
Krefeld 13
Belo Horizonte 12
Biên Hòa 12
Kingston 12
Querétaro 12
Bari 11
Guarulhos 11
Lahore 11
Lawrence 11
Manchester 11
Turku 11
Verona 11
Bad Bellingen 10
Brescia 10
Brussels 10
Dong Ket 10
Figino 10
Medellín 10
Ninh Bình 10
Paris 10
Porto Alegre 10
Buenos Aires 9
Cagliari 9
Charlotte 9
Totale 7.343
Salva come PNG Salva come JPEG
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 750
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 505
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 478
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 362
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 337
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 309
[Ten perspectives for research and innovation in cardiac amyloidosis] 309
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 288
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 273
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 269
[Transcatheter devices for chronic heart failure: state of the art] 265
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 256
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 255
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 255
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 254
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 253
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 252
Valvular heart disease in patients with cardiac amyloidosis 244
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 244
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 238
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 237
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 233
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 233
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 231
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 229
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 227
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 223
The chronic heart failure evolutions: Different fates and routes 223
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 221
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 208
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 206
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 204
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 203
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 201
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 200
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 189
Change in prevalence of ATTR variants in Italy: results from a national survey 187
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 185
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 181
Cardiac amyloidosis: when to suspect and how to confirm 170
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 164
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 151
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 128
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 122
Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry 110
Clinical phenotype and prognosis of real-world patients with wild-type transthyretin amyloid cardiomyopathy treated with tafamidis 104
Natural History of Patients With Histologically Proven Acute Eosinophilic Myocarditis 101
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: The MECKI-RENAL study 93
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 91
Light chain amyloidosis: multidisciplinary management and innovative therapeutic strategies. SIC/ANMCO Consensus document of the Italian Cardiac Amyloidosis Network (RIAC) 89
Current Standards and Perspectives in Proteomics for Cardiac Amyloidosis 84
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 84
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis 84
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study 76
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 76
Analysis of Calcium Scores in Severe Aortic Stenosis Patients With and Without Cardiac Amyloidosis: The CAUSATIVE Study 74
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 69
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 66
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 65
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impact 57
Electrocardiographic abnormalities in patients with cardiomyopathies 52
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 50
High Prevalence of Wild-Type Transthyretin Cardiac Amyloidosis in Older Adults with Carpal Tunnel Syndrome, Heart Failure or Increased Left Ventricular Mass: The CAPTURE Study 32
Totale 12.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022128 0 0 0 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/20251.825 31 81 137 52 112 90 243 397 160 70 265 187
2025/20268.713 311 944 1.798 876 686 503 715 488 709 564 589 530
2026/20271.260 260 271 607 122 0 0 0 0 0 0 0 0
Totale 12.609